Simplify Propel Opportunities ETF SURI AMEX · Financials · United States
$15.51 -0.21% -$0.03
Summary
Simplify Propel Opportunities ETF is an ETF - a fund traded on an exchange like a stock - run by Simplify. Positions inside: 38. The ten largest make up 83% of the fund.
- Yearly costs
- 2.84%
- Fund size
- $70.1M
- Positions
- 38
- Dividend yield
- 17.54%
- Running since
- 2023
What speaks for it
Nothing stands out in its favour.
What to watch
- The ten largest positions make up 83% of the fund, so its result rests on a few names.
- 55% of the fund is in one sector (Healthcare).
- 93% of the fund is in one country (United States).
- Costs of 2.84% a year are above the middle of comparable funds (0.45%).
- In the last five years its price once dropped by 52% from its high.
- A small fund with $70.1M under management; small funds get closed more often.
- It trades little: only about $69.9K changes hands a day.
A fund has no Bulios Score and no Fair Price of its own - both are computed from the results of a single company. This page shows what is inside the fund and what it costs instead.
Price
Performance
- 1 month
- -6.6%
- 3 months
- -20%
- This year
- -6.8%
- 1 year
- -7.4%
- 3 years
- -19%
- Avg. market cap
- $3.19B
- P/E
- 12.2x
- Forward P/E
- 12.0x
- P/S
- 0.2x
- P/B
- 3.3x
- P/FCF
- 2.8x
- EV/EBITDA
- 6.5x
- Dividend yield
- 3.23%
- ROIC
- -18.5%
- ROE
- -64.9%
- Gross margin
- -135.8%
- Operating margin
- -5,440.5%
- Net margin
- -5,175.6%
- Payout ratio
- 39.3%
- Net debt/EBITDA
- 1.9x
- Beta
- 1.19
Weighted average of the 21 largest companies, which make up 63% of the fund. Banks and insurers are left out of the gross margin, the ROIC and the EBITDA figures.
What is inside?
Concentrated- 1 PAPlains GP Holdings, L.P. PAGP 32%
- 2 SBSimplify Government Money Market ETF SBIL 15%
- 3 ACHIEVE LIFE SCIENCES INC USD 0.001 8.4%
- 4 Cash 6.2%
- 5 DCDelcath Systems, Inc. DCTH 6.1%
- 6 ACHIEVE LIFE SCIENCES I WTS 30JUN30 4.6%
- 7 COCollegium Pharmaceutical, Inc. COLL 3.4%
- 8 OBOrchestra BioMed Holdings, Inc. OBIO 2.7%
- 9 MIMilestone Pharmaceuticals Inc. MIST 2.5%
- 10 PHPhathom Pharmaceuticals, Inc. PHAT 2.2%
Positions in the fund: 38. The ten largest make up 83% of it.
Composition as of Nov 14, 2026.
Where is it spread?
One sector dominatesBy sector
- Healthcare 55%
- Energy 45%
By country
- United States 93%
- Canada 3.5%
- France 2.3%
- United Kingdom 1.6%
By company size
- Mid cap 55%
- Small cap 33%
- Micro cap 11%
By the company's market value: Mega cap from $200B, Large cap from $10B, Mid cap from $2B, Small cap from $300M, Micro cap below $300M. Counted from the companies that make up 63% of the fund.
Largest sector: Healthcare (55%). Largest country: United States (93%). Largest size group: Mid cap (55%).
What does it cost me?
Expensive- A year from $10,000
- $284
- Over 20 years
- $11,200
From every $10,000 invested the fund takes $284 a year. You do not pay it separately - it is taken out of the fund's value. Over 20 years at 5% yearly growth that adds up to about $11,200.
How has it done?
Losing value- A year on average, 3 years
- -6.7%
- Deepest drop
- -52%
- Yearly volatility
- 23%
Average yearly decline over the last three years: 6.7%. Deepest drop in these years: 52% below the earlier high.
Does it pay dividends?
Yes, it pays out- Yield
- 17.54%
- Payments a year
- 4
- Last payment
- $0.68
Over the last 12 months it paid $2.72 per share, which is 17.54% of today's price. The last payment was $0.68 on Sep 25, 2026.
Is it easy to buy and sell?
It trades little- Traded a day
- $69.9K
- Shares a day
- 4.5K
On an average day about $69.9K of the fund changes hands.
How expensive are the companies inside?
Rather cheap- P/E of the companies inside
- 12.2
- Average Bulios Score
- 48 out of 100
Weight by Bulios Fair Price
- Undervalued 69%
- Fairly valued 4.0%
- Overvalued 27%
On average the companies inside trade for 12.2 times their yearly profit. By Fair Price, 69% of the rated weight comes out as undervalued.
Counted from its largest companies (21), which make up 63% of the fund. Each company counts by its weight. We use the metrics, the Bulios Score and the Fair Price of the companies themselves.